Fuva Brain Ltd. (3927) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Fuva Brain Ltd. (3927:JPX), powered by AI.

Current Price
¥882
P/E Ratio
42.5
Market Cap
4.7B
Sector
Technology
What is the Fuva Brain Ltd. stock price forecast?

Fuva Brain Ltd. is currently trading at ¥882. View real-time AI analysis on Alpha Lenz.

What is Fuva Brain Ltd. insider trading activity?

View the latest insider trading data for Fuva Brain Ltd. on Alpha Lenz.

What is Fuva Brain Ltd.'s P/E ratio?

Fuva Brain Ltd.'s P/E ratio is 42.5.

Fuva Brain Ltd.

JPX · 3927
¥882-6(-0.68%)Market closedJPX regular session 09:00–15:00 JST
Ask about Fuva Brain Ltd.'s future dividend policy...
Alpha Chat Insight

Fuva Brain Ltd. trades at a P/E of 42.5 (premium valuation) with modest ROE of 7.6%. 3Y revenue CAGR of 37.5% highlights clear growth momentum.

Ask for details

Company Overview

Fuva Brain Ltd. is a company known for developing and distributing a variety of nutritional supplements focused on cognitive health and wellness. It primarily aims to enhance brain function and support mental well-being through its innovative product lines. The company's offerings include supplements that target memory improvement, stress reduction, and overall mental performance. These products are designed to cater to various consumer segments ranging from students to professionals seeking mental acuity and seniors looking to maintain cognitive health. With a commitment to research and development, Fuva Brain Ltd. collaborates with scientific experts to ensure evidence-backed formulations, thereby positioning itself as a trusted brand in the health and wellness industry. It plays a significant role in the dietary supplements market, contributing to the growing trend of preventative healthcare and wellness consciousness among consumers. By focusing on quality and efficacy, Fuva Brain Ltd. aims to meet the increasing demand for natural health solutions while potentially influencing the broader nutraceutical landscape.

SectorTechnology
IndustrySoftware - Infrastructure
Employees256

Company Statistics

FY 2025

Profile

¥4,653,177,102Market Cap
¥4,373,104,000Revenue
0.00Shares Out
256Employees

Margins

29.82%Gross
5.26%EBITDA
4.29%Operating
3.71%Pre-Tax
3.43%Net

Valuation

42.51P/E
3.03P/B
1.06EV/Sales
16.03EV/EBITDA
-173.32P/FCF

Growth (CAGR)

37.48%Rev 3Yr
33.08%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

3.02%ROA
7.61%ROE
3.31%ROIC

Financial Health

¥1,522,935,000Cash & Cash Equivalents
¥2,351,660,000Net Debt
224.01%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Fuva Brain Ltd. (ticker: 3927) is a company listed on JPX in the Technology sector (Software - Infrastructure). It has approximately 256 employees. Market cap is $4.7B.

The current price is 882 with a P/E ratio of 42.51x and P/B of 3.03x.

ROE is 7.61% and operating margin is 4.29%. Annual revenue is $4.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Fuva Brain Ltd. (3927) Stock Forecast 2026 ¥882 — Price, Financials & Analyst Targets | Alpha Lenz